Selected Recent TB Articles/Publications
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis in Lancet Respir Med
Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study in Clin Infect Dis
Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort in Am J Kidney Dis.
Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials in Clin Infect Dis.
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis in Lancet.
Diagnostic accuracy of centralised assays for TB detection and detection of resistance to rifampicin and isoniazid: A systematic review and meta-analysis in Eur Respr J
Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs in CMAJ.
A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children in EBioMedicine
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients in Eur Respir J
Global health degrees: at what cost? in BMJ GH.
Advances in Molecular Diagnosis of Tuberculosis in JCM
Changes in Treatment for Multidrug-Resistant Tuberculosis According to National Income in Eur Respir J
Diagnostic Accuracy of Serological Tests for covid-19: Systematic Review and Meta-Analysis in The BMJ
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings in Ann Intern Med.
How Well Does TSTin3D Predict Risk of Active Tuberculosis in the Canadian Immigrant Population? An External Validation Study in Clin Infect Dis
